BOSTON--(BUSINESS WIRE)--Oxford Bioscience Partners is pleased to announce that Dr. Douglas Fambrough has been promoted to the position of General Partner. Dr. Fambrough has been involved with a series of Oxford portfolio company investments that have created value both for investors as well as for society at large through the advancement of pharmaceutical research and development. These investments are exemplars of Oxford’s commitment to the profitable advancement of innovation in biotechnology through cutting-edge technology.
